An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors by Dean, Justin M et al.
RESEARCH ARTICLE Open Access
An organotypic slice culture model of chronic
white matter injury with maturation arrest of
oligodendrocyte progenitors
Justin M Dean
1, Art Riddle
1, Jennifer Maire
1, Kelly D Hansen
1, Marnie Preston
3, Anthony P Barnes
1,
Larry S Sherman
3 and Stephen A Back
1,2*
Abstract
Background: CNS myelination disturbances commonly occur in chronic white matter lesions in
neurodevelopmental and adult neurological disorders. Recent studies support that myelination failure can involve a
disrupted cellular repair mechanism where oligodendrocyte (OL) progenitor cells (OPCs) proliferate in lesions with
diffuse astrogliosis, but fail to fully differentiate to mature myelinating OLs. There are no in vitro models that
reproduce these features of myelination failure.
Results: Forebrain coronal slices from postnatal day (P) 0.5/1 rat pups were cultured for 1, 5, or 9 days in vitro
(DIV). Slices rapidly exhibited diffuse astrogliosis and accumulation of the extracellular matrix glycosaminoglycan
hyaluronan (HA), an inhibitor of OPC differentiation and re-myelination. At 1 DIV ~1.5% of Olig2
+ OLs displayed
caspase-3 activation, which increased to ~11.5% by 9 DIV. At 1 DIV the density of PDGFRa
+ and PDGFRa
+/Ki67
+
OPCs were significantly elevated compared to 0 DIV (P < 0.01). Despite this proliferative response, at 9 DIV ~60% of
white matter OLs were late progenitors (preOLs), compared to ~7% in the postnatal day 10 rat (P < 0.0001),
consistent with preOL maturation arrest. Addition of HA to slices significantly decreased the density of MBP
+ OLs at
9 DIV compared to controls (217 ± 16 vs. 328 ± 17 cells/mm
2, respectively; P = 0.0003), supporting an inhibitory
role of HA in OL lineage progression in chronic lesions.
Conclusions: Diffuse white matter astrogliosis and early OPC proliferation with impaired OL maturation were
reproduced in this model of myelination failure. This system may be used to define mechanisms of OPC
maturation arrest and myelination failure related to astrogliosis and HA accumulation.
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Introduction
Disturbances in CNS myelination are a central feature of
numerous neurodevelopmental and adult neurological
disorders, and are widely recognized to occur in areas of
reactive astrogliosis. Although myelination disturbances
frequently involve oligodendrocyte (OL) degeneration
[1-3], emerging evidence supports that OL progenitor
cells (OPCs) exhibit a robust regenerative response to
injury. In chronic white matter lesions, OPCs proliferate
but fail to fully differentiate to mature myelinating OLs,
supporting the concept that failure to generate new
myelin is related to arrest of oligodendrocyte maturation
[4-6].
The mechanisms that mediate inhibition of OL
maturation following CNS insults are largely unknown.
Reactive astrogliosis is linked to OPC maturation arrest
and remyelination failure in a number of conditions
[7-9], and both Notch signaling and bone morphoge-
netic proteins induced during reactive gliosis have been
implicated in these inhibitory processes [10,11]. Release
of hyaluronan (HA) by reactive astrocytes also appears
to be an important regulator of CNS myelination [12],
and HA can arrest OPC maturation both in vitro and in
vivo [13,14]. HA is a non-sulfated, protein-free
* Correspondence: backs@ohsu.edu
1Department of Pediatrics, Oregon Health & Science University, 3181 SW
Sam Jackson Park Road, Portland, Oregon 97239, USA
Full list of author information is available at the end of the article
Dean et al. Molecular Neurodegeneration 2011, 6:46
http://www.molecularneurodegeneration.com/content/6/1/46
© 2011 Dean et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.glycosaminoglycan that forms an integral part of the
extracellular matrix. In the CNS, HA is predominantly
synthesized by astrocytes, and can accumulate in areas
of chronic astrocytosis and myelination disturbance [15].
HA and its receptor CD44 are robustly expressed in
white matter lesions with diffuse astrogliosis, consistent
with the response observed in demyelinating lesions,
traumatic spinal cord injury, vascular brain injury asso-
ciated with dementia, and ischemic lesions in adult
humans and rodents [14,16,17]. The molecular mechan-
isms by which HA inhibits OL maturation are largely
unknown, and as yet, there are no well-established in
vitro models that reproduce the major features of
chronic white matter lesions.
Herein, we developed a slice culture model of reactive
astrogliosis that exhibited accumulation of HA in the
white matter, with associated OPC proliferation but
impaired maturation. Addition of HA to this system
further impaired OPC maturation, providing support for
an inhibitory role of HA in OL lineage progression. This
chronic white matter injury model thus provides a novel
system to define mechanisms of myelination failure
related to astrogliosis and disturbances in oligodendro-
cyte maturation.
Results
Organotypic slice cultures display progressive diffuse
astrogliosis and HA accumulation
Intact whole coronal forebrain slices containing white
matter and overlying cortex were cultured from postna-
tal day 0.5/1 (P0.5/1) rats. To investigate the glial injury
response in this slice culture model, we analyzed immu-
nohistochemical expression of GFAP (astrocytes) and
Iba1 (microglia/macrophages) in the white matter at 0,
1, 5, and 9 days in vitro (DIV). At 0 DIV (i.e., P0.5/1 rat
brain with no culture), there was negligible expression
of GFAP in the white matter (Figure 1A), and low
expression of Iba1 (Figure 1E) in cells that exhibited a
resting morphology (Figure 1E inset). Compared to 0
DIV (Figure 1A), there was a rapid and progressive up-
regulation of GFAP expression in astrocytes (Figure 1B-
D) and Iba1 in microglia/macrophages (Figure 1E-H).
Both cell types exhibited a reactive morphology (GFAP
+
c e l l s ,F i g u r e1 Di n s e t ;I b a 1
+ cells, Figure 1H inset).
Overall, these data supported a pattern of progressive
reactive gliosis.
Next, we detected HA expression with a biotinylated
hyaluronan (HA) binding protein (bHABP). At 0 DIV
(Figure 1I), there was low HA expression in the white
matter, followed by a progressive increase from 1 DIV
to 9 DIV (Figure 1J-L). Elevated HA was observed pre-
dominantly in areas of gliosis (Figure 1M-O), with a
characteristic pericellular pattern of expression (Figure
1P), consistent with previous observations [14]. Hence,
chronic slice cultures displayed diffuse astrogliosis and
HA accumulation similar to that observed in chronic
cerebral whiter matter lesions in vivo.
Oligodendrocyte (OL) survival and progenitor responses
in white matter of organotypic slice cultures
To investigate survival of the total OL lineage in this
slice culture model, we examined the density of cleaved
caspase-3 (CC3)-positive cells (Olig2
+) in the white mat-
ter at 1 DIV, 5 DIV, and 9 DIV (Figure 2A, B). Approxi-
mately 1.5% of all Olig2
+ cells were positive for CC3 at
1 DIV. There was a progressive but non-significant
increase to ~11.5% by 9 DIV.
To examine the response of OPCs in the white matter
of this slice culture model, we examined the density of
PDGFRa
+ OPCs and their co-localization with the prolif-
eration marker Ki67 at 0 DIV, 1 DIV, 5 DIV and 9 DIV
(Figure 2C). At 1 DIV, there was a significant increase in
the density of both PDGFRa
+ cells and PDGFRa
+/Ki67
+
double-labeled cells compared to 0 DIV (ANCOVA +
Tukey’st e s t ;P < 0.01, for both), consistent with OPC
proliferation. By 5 DIV and 9 DIV the density of both
PDGFRa
+ cells and PDGFRa
+/Ki67
+ double-labeled cells
returned to 0 DIV levels. With increasing time in culture,
PDGFRa
+ OPCs exhibited a reactive-type of morphology,
with increased cell body size and process thickness, as
well as more extensive process arborization and complex-
ity (Figure 2D-F). Hence, this slice culture model was
associated with an acute phase of rapid OPC proliferation
resulting in a net expansion in the OPC pool, followed by
a delayed phase of degeneration.
Delayed OPC maturation in white matter of organotypic
slice cultures
To determine the timing of OPC maturation, we quanti-
fied the relative percentages of late oligodendrocyte pre-
cursors (preOLs; O4
+/O1
-)a n di m m a t u r e
oligodendrocytes (immature OLs; O4
+/O1
+) in slice cul-
tures at 9 DIV compared to the normal rat brain at an
equivalent postnatal age (P10). Rat brains at P10 only
expressed 7 ± 2% preOLs in the white matter (Figure
3A, E). Most O4
+/O1
+ immature OLs displayed a
reduced process arbor and extensive early myelination
( F i g u r e3 C ) .B yc o n t r a s t ,t h e r ew e r e6 0±1 %p r e O L si n
the white matter in this slice culture model at 9 DIV
(Figure 3B, E; P < 0.0001). Interestingly, both preOLs
and immature OLs displayed a reactive morphology,
with a hypertrophic cell body and an extensive arbor of
processes (Figure 3D) relative to normal brain at P10
(Figure 3C). Some O4
+/O1
+ OLs showed a highly
branched morphology consistent with mature OLs (Fig-
ure 3F). Hence, the maturation of OPCs in this slice
model was markedly delayed relative to the normal rat
brain, with arrested OL maturation at the preOL stage.
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slice cultures
We examined the immunohistochemical expression of
MBP in the white matter at 1 DIV, 5 DIV, 9 DIV, and
13 DIV. At 1 DIV there were no MBP
+ cells in the slice
cultures (Figure 4A). By 5 DIV a low number of MBP
+
mature OLs were observed (Figure 4B). By 9 DIV there
was a marked increase in expression of individual MBP
+
cells (Figure 4C). The MBP
+ cells at 9 DIV were highly
branched but largely occupied individual domains, and
Figure 1 Development of white matter gliosis in ex vivo slice culture model. (A-D) Compared to 0 DIV (A), there was a marked increase in
GFAP
+ astrocytes in the white matter at 1 DIV (B), 5 DIV (C), and 9 DIV (D), and cells exhibited a reactive phenotype (D, inset). (E-H) Compared
to 0 DIV (E), there was a marked increase in Iba1
+ microglia/macrophages in the white matter at 1 DIV (F), 5 DIV (G), and 9 DIV (H), and cells
exhibited a reactive phenotype (H, inset). (I-L) bHABP staining at 0 DIV (I) was low in the white matter in contrast to the elevated staining in the
peri-neuronal nets of the cerebral cortex. Compared to 0 DIV (I), there was a progressive increase in bHABP in the white matter at 1 DIV (J), 5
DIV (K), and 9 DIV (L). (M-O) In contrast to the cortex, areas of white matter gliosis (M) were enriched in bHABP staining (N); double labeling is
shown in O. (P) HA (red) exhibited a perinuclear pattern in areas of gliosis (GFAP, green). Scale: A-H, 100 μm; I-O, 200 μm; P, 25 μm; Insets D, E,
H, 10 μm. Ctx, cortex; SVZ, subventricular zone; WM, white matter.
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Page 3 of 10Figure 2 Oligodendrocyte (OL) survival and oligodendrocyte progenitor proliferation in the white matter of ex vivo slice culture
model. (A) Percentage of total OL lineage cells in the white matter that labeled with cleaved caspase-3
+ (CC3). Data are mean ± SEM (n = 3-4
slices per time point). (B) Example of CC3
+ (red, arrows) and Olig2
+ (green, arrowheads) cells (co-localized cells are shown in yellow). (C) Density
of PDGFRa
+ (black bars, left axis) and co-localized PDGFRa
+/Ki67
+ OPCs in the white matter. Data are mean ± SEM (n = 6 slices per time point
from two independent experiments). *P < 0.01 (ANOVA followed by Tukey’s multiple comparison test; uncorrected data). †P < 0.01 (ANCOVA
followed by Tukey’s multiple comparison test; data corrected for atrophy). (D-F) PDGFRa
+ OPCs in the white matter at 0 DIV (D), 1 DIV (E) and 5
DIV (F). The inset in E shows a PDGFRa
+ (green)/Ki67
+ (red) double labeled OPC. Scale: B, D-F, 20 μm; E inset, 10 μm.
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Page 4 of 10Figure 3 Oligodendrocyte maturation is delayed in the white matter of the ex vivo slice culture model compared to normal white
matter development in vivo. Representative photomicrographs of preOLs (green; arrows) and immature OLs (yellow; arrowheads) double-
labeled with O4 (green) and O1 (red) antibodies in the P10 rat (A, C) and the white matter of the 9 DIV slice (B, D, F). (A, C) The P10 rat
white matter contained numerous immature OLs (arrowheads) and myelin sheaths (asterisk). (B, D) Slice cultures contained predominantly
preOLs (green; arrows) with occasional immature OLs (yellow; arrowheads). Both preOLs and immature OLs in the slice cultures showed a
reactive morphology, with extensive process extension and cytoplasmic swelling when compared with normal brain at P10 (C). (E)
Percentage of preOLs in the white matter of P10 rat (white bar) vs. organotypic slice culture at 9 DIV (Black bar). Data are mean ± SEM (9
DIV slice data: n = 11 slices from three independent experiments; P10 rat data: n = 6 animals). *P < 0.0001 (unpaired two-way t-test). (F)
Some O4
+/O1
+ OLs in slice culture showed a highly branched morphology (arrowhead) suggestive of a mature OL; arrow indicates a preOL.
Scale: A, B, 50 μm; C, D, F, 10 μm.
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Olig2 (Figure 4D). At 13 DIV a small number of MBP
+
cells appeared to be initiating myelination (Figure 4E,
F). Despite the presence of a subpopulation of mature
OLs in the white matter, there was thus a pronounced
reduction in myelination compared to the normal rat
brain at P10 (Figure 3C) or P14 [18,19].
Exogenous hyaluronan impairs oligodendrocyte
maturation in white matter of organotypic slice cultures
We added high molecular weight HA to this slice cul-
ture system to examine its role in regulating oligoden-
drocyte maturation. At 9 DIV there was a significant
decrease in the density of MBP
+ oligodendrocytes in the
white matter in slices treated with HA compared to
those treated with PBS (~34%; 217 ± 16 vs. 328 ± 17
cells/mm
2, respectively; P = 0.0003; Figure 5A-C).
Hence, exogenous HA further reduced the level of OL
maturation relative to that in untreated chronic slices
where OL maturation was already markedly lower than
equivalent age uninjured control animals.
Discussion
The normal regulation of oligodendrocyte (OL) matura-
tion and myelination in the CNS is critical for normal
vertebrate function, as well as to promote recovery fol-
lowing white matter injury. Dissociated OL cultures
have provided important information on many aspects
of these processes. Nevertheless, there are no well-estab-
lished in vitro models that accurately model the chronic
gliotic lesions often observed in disorders with myelina-
tion failure. There is now increasing interest in the use
of organotypic slice cultures for studies of OL biology
and myelination due to retention of multi-cellular inter-
actions and the ease of manipulation [20-22]. However,
we found that organotypic slice cultures display features
consistent with a chronic white matter injury in vivo,
which included white matter gliosis, cell death, OPC
proliferative and reactive responses and arrested OL
lineage maturation. Hence, when employing a chronic
slice culture model for studies of normal oligodendro-
glial biology or myelination, these chronic injury
responses should be considered.
Figure 4 Timing of myelin onset in white matter of ex vivo slice culture model. MBP expression at 1 DIV (A), 5 DIV (B), and 9 DIV (C) in
white matter of organotypic slice cultures. There was a progressive increase in MBP expression in the white matter with time in culture. (D) At 9
DIV, robust expression of individual MBP positive cells was observed, which were co-localized with the oligodendrocyte nuclear transcription
factor Olig2 (MBP: green, Olig2: red). (E) Evidence of onset of myelination in the white matter at 13 DIV. (F) Oligodendrocyte (arrow; DAPI: shown
as pseudo-color in red) showing wrapping of axons stained with MBP (green; arrowhead). Scale: A-C, 500 μm; D, F, 20 μm; E, 250 μm.
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OL response to white matter injury, we found rapid and
progressive reactive astrocytosis and microglia/macro-
phage accumulation in the white matter of slice cul-
tures, as well as an early proliferative response of OPCs.
This expanded pool of OPCs exhibited a reactive
morphology, delayed OL degeneration, and impaired
maturation of preOLs to OLs. Delayed OPC maturation
did not appear to be region-specific and cortical OPC
maturation by 9 DIV also was delayed relative to the
extensive myelination that occurs in vivo by postnatal
day 10. These in vitro responses are very similar to
those first described in neonatal rodents following
hypoxia-ischemia, where despite extensive OL degenera-
tion, there was a rapid proliferative response of OPCs,
subsequent failure of preOLs to mature in chronic
astrogliotic lesions, and persistent myelination deficits
[4]. A role for OL maturation arrest in developmental
myelination disturbance is supported by more recent
studies in preterm fetal sheep following hypoxia-ische-
mia [23] and in preterm human autopsy cases with
chronic white matter injury (Buser et al., submitted).
OPCs also accumulate but fail to mature to myelinating
OLs in chronic demyelinated lesions in multiple sclero-
sis patients [24-26]. In a recent postmortem study of
brains from human cases of age-related cognitive decline
associated with vascular brain injury, a significant
increase in the total pool of OLs was correlated with
changes in MRI-defined diffusion characteristics consis-
tent with white matter myelin deficits [27].
Our slice culture system exhibited a progressive
increase in expression of HA in the white matter with
time in culture, while addition of exogenous HA further
inhibited OL maturation. These data suggest a role for
endogenously released HA in mediating the impairment
of OL maturation observed in this system, and support
previous studies where addition of HA reversibly
impaired maturation of cultured OPCs and inhibited
remyelination after lysolethicin-induced white matter
demyelination [13,14]. Accumulation of HA was also
reported following traumatic spinal cord injury [16] and
middle cerebral artery occlusion [28] in adult rats, and
in stroke-affected brain regions in adult humans [29],
although myelination deficits were not examined. The
increase in white matter HA in the slice cultures was
likely a response to the reactive astrogliosis, because in
the CNS, HA is predominantly produced by astrocytes
[30]; however, we cannot discount a role of other CNS
glia. The reactive gliosis observed in this system was
likely a response to neuronal and glial degeneration sec-
ondary to generation of the tissue slices.
Conclusions
This model provides a novel system to define mechan-
isms that regulate disturbances in oligodendrocyte
maturation and myelination failure related to chronic
CNS astrogliosis. Future studies will utilize this model
to determine the signaling pathways by which HA regu-
lates oligodendrocyte development in the setting of
chronic white matter injury.
Figure 5 Hyaluronan impairs oligodendrocyte maturation in
organotypic slice cultures. (A) Density of MBP
+ oligodendrocytes
in the white matter at 9 DIV in PBS (Black bar) and HA (white bar)
treated slices. Data are mean ± SEM (n = 9 slices per time group
from three independent experiments). *P < 0.0005 (unpaired two-
way t-test). (B, C) Representative photomicrographs of 9 DIV slices
stained with MBP in the PBS (B) and HA (C) treatment groups. Scale:
B, C, 100 μm.
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Postnatal brain slice preparation and culture
All animal procedures were approved by the OHSU
Institutional Animal Care and Use Committee (IACUC)
according to the NIH Guide for the Care and Use of
Laboratory Animals. Timed pregnant Sprague-Dawley
(SD) rats were purchased from Charles River (Hollister,
CA, USA). Whole forebrain coronal slices (300 μm; col-
lected at the level of the rostral corpus callosum and
anterior septal nuclei; 3 adjacent slices from each brain)
collected from postnatal day (P) 0.5/1 rat pups were
used to prepare organotypic cultures according to a pre-
vious method [31], with modifications. Brains were
embedded in 1.5% low melting point agar (Fischer
Scientific, Fair Lawn, NJ, USA) and sectioned into sterile
ice-cold complete Hank’s balanced salt solution (HBSS,
Ca
2+/Mg
2+ free [Invitrogen Co., Carlsbad, USA], supple-
mented with D-glucose [30 mM), HEPES buffer [2.5
mM], CaCl2 [1 mM], MgSO4 [1 mM], NaHCO3 [4
mM], and 0.001% phenol red [Sigma-Aldrich Co., St.
Louis, MO, USA]) using a VTS 1600 vibrating micro-
tome (Leica Microsystems Inc., Buffalo Grove, USA).
Isolated slices were transferred onto 0.4 μmp o r o u s
membrane cell culture inserts (Becton Dickinson, Frank-
lin Lakes, NJ, USA) that were pre-coated with laminin/
poly-D-lysine (Sigma-Aldrich Co.), and cultured in slice
culture media (Basal Medium Eagle [Invitrogen Co.],
supplemented with complete HBSS [25% v/v], D-glucose
[27 mM], penicillin [100 U/mL], streptomycin [100 U/
mL], glutamine [1 mM; Sigma-Aldrich Co.], and 5%
horse serum [New Zealand origin, heat inactivated; Invi-
trogen Co.]). Slices were incubated at 37°C/5% CO2, and
the growth medium changed daily. In pilot experiments
we determined that 5% serum resulted in optimal acute
survival of the slices when compared to 25% serum, as
previously reported [21].
Time course experiments
Slices were collected at 1, 5, 9, or 13 days in vitro (DIV),
fixed in 4% paraformaldehyde (PFA; 0.1 M phosphate
buffered saline [PBS]) for 1 h at RT, and washed thor-
oughly in PBS prior to immunohistochemical staining.
As controls, slices were fixed immediately after cutting
(0 DIV; i.e., no culture).
Hyaluronan experiments
High molecular weight hyaluronan (1.59 × 10
6 Da; Sei-
kagaku Co., Tokyo, Japan) was dissolved in sterile PBS
(5 mg/mL), and then added daily to fresh slice growth
medium (final concentration, 100 μg / m L )f r o m0D I V
until 9 DIV [14]. Slices were then processed for immu-
nohistochemistry as described.
Immunohistochemistry
Single- or double-labeling immunofluorescence was per-
formed on sections in 24-well plates. Antibodies and
dilutions are shown in Table 1. For PDGFRa/Ki67 dou-
ble labeling and O4 and O1 antibody double labeling,
sections were blocked for 1 h in PBS containing 5% nor-
mal goat serum (NGS), and then with primary antibo-
dies diluted in PBS/3% NGS for 72 h at 4°C [4]. For all
other antibodies, sections were incubated in 0.01 M
citrate buffer (pH 6.0) at 85°C for 20 min, left to cool
for 20 min, and then washed three times in PBS. Block-
ing and primary antibody incubation was performed as
above, with the addition of 0.4% triton X-100 (Sigma-
Aldrich Co.). For secondary detection, all sections were
washed three times in PBS, and incubated with
Table 1 Antibodies and markers
Antigen Host Marker Dilution Supplier
Biotinylated hyaluronan binding
protein (bHABP)
Bovine Hyaluronan 1:200 Associates of Cape Cod, Inc., East Falmouth, MA
Cleaved caspase-3 (CC3) Polyclonal Rabbit Apoptotic cells 1:500 Cell Signaling Technology, Danvers, MA
GFAP Polyclonal Rabbit Astrocytes 1:500 Dako North America, Inc., Carpinteria, CA
Iba1 Polyclonal rabbit Microglia/macrophage 1:500 Wako Chemicals USA Inc., Richmond, VA
Ki67 Monoclonal
mouse
Cell Cycle Activation 1:200 Novocastra, Buffalo Grove, IL
MBP Mouse Mature OL 1:500 Covance, Princeton, NY
O1 Monoclonal
mouse IgM
Immature/mature OL 1:3000 Dr. Rashmi Bansal (University of Connecticut Health
Center, Farmington, CT)
Biotinylated O4 Monoclonal
mouse IgM
Late OL progenitor/
immature OL
1:500 Research Genetics, Huntsville, AL
PDGFRa Polyclonal rabbit OL progenitor 1:1000 R&D Systems, Minneapolis, MN
Olig2 Mouse Oligodendrocyte (OL) 1:250 Dr. John Alberta (Dana-Farber Cancer Institute, Boston,
MA
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ondary antibodies (1:500, all raised in goat; Invitrogen
Co.). Nuclei were counterstained with DAPI (Invitrogen
Co.). No-primary-control studies for all antibodies
exhibited no positive staining. Sections were mounted
with Vectashield fluorescent mounting medium (Vector
Laboratories, Inc., Burlingame, CA, USA).
Cell quantification
The white matter of cultured slices was analyzed using a
Leica DMIRE2 inverted fluore s c e n c em i c r o s c o p e( L e i c a
Microsystems Inc., Buffalo Grove, IL, USA) coupled to a
Stereoinvestigator stereology system (MBF Bioscience,
Williston, VT, USA). For each slice, the entire white
matter (defined by DAPI-staining) region of interest
(ROI) was traced at 5 × magnification. Using the soft-
ware to maintain white matter boundaries, cell counts
were performed using the optical fractionator probe
(Grid size, 300 × 400 μm; Counting frame, 30 × 30 μm;
z-depth 20 μm) at 40 × magnification in a minimum of
10 randomly selected white matter fields per slice. The
slice thickness was also measured at each counting site.
Cell density (mm
2) was calculated by the formula: [cell
counts/(number of fields × counting frame area (mm
2))].
Statistics
An unpaired two-tailed t-test was used to compare per-
centage OLs between normal rat brain and the slice cul-
tures. One-way analysis of variance (ANOVA) followed
by Tukey’s multiple comparison test was used to assess
changes in percentage CC3
+ OLs in the white matter
over time in culture. To determine the effect of slice
atrophy on PDGFRa cell density measurements, we
quantified mean white matter volume. For each slice,
white matter volume was calculated from white matter
ROI area × mean white matter thickness (determined
from all count sites) as acquired during cell counting.
One-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test was first run to deter-
mine relative atrophy with time in culture. There was a
significant overall effect of group (P < 0.01), with a sig-
nificant decrease in white matter volume at 5 DIV and 9
DIV compared to other ages (white matter volume,
mm
3: 0 DIV, 0.26 mm
3; 1 DIV, 0.29 mm
3;5D I V ,0 . 1 8
mm
3;9D I V ,0 . 1 8m m
3; P < 0.05), which was attributed
to a shrinkage of the white matter ROI area rather than
in the z-plane of the slice (data not shown). Because of
this reduction in white matter volume, we accounted for
degree of atrophy by using white matter volume as a
covariate when comparing cell density measurements
between time in culture using a one-way analysis of cov-
a r i a n c e( A N C O V A )f o l l o w e db yT u k e y ’s multiple com-
p a r i s o nt e s t .C e l ld e n s i t yd a t aw e r ep r e s e n t e d
uncorrected for atrophy. A P-value less than 0.05 was
considered statistically significant. All data are presented
as mean ± standard error of the mean (SEM), with sig-
nificance indicated for both ANOVA and ANCOVA
analyses (For figure 2, *P <0 . 0 1r e f e r st oa n a l y s i so f
uncorrected data by ANOVA; †P < 0.01 refers to analy-
sis of data corrected for slice atrophy by ANCOVA).
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